One such industry is healthcare. And here are two healthcare stocks to consider for diversification, if you are heavily ...

While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the ...

The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is ...

A health and national security cess and excise duty on pan masala and tobacco products respectively will be over and above 40 ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration ...

The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients and ...

Here are five healthcare themes to watch next year, and which stocks stand to benefit. Key names to watch include Eli Lilly, ...

Earlier this month, Donald Trump took a break from his busy schedule of watching TV and overseeing the renovation of his taxpayer-financed mansion to rally his constituents. “They always have a ...

President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Watch in our video player above. Pharmaceutical companies Amgen, ...

President Trump said the administration has reached agreements with nine more drugmakers to bring their U.S. drug prices more in line with what other wealthy countries pay. Fourteen companies in total ...

WASHINGTON, Dec 19 (Reuters) - U.S. President Donald Trump on Friday said he wants to meet with health insurers in coming weeks in a bid for lower prices, saying that could be another way to lower ...